Literature DB >> 1537905

Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.

B Ma1, B Christen, D Leung, C Vigo-Pelfrey.   

Abstract

The significance of various antibodies against Borrelia burgdorferi was studied by Western blot (immunoblot) by using 578 human serum samples. The proteins regularly detected by using samples from patients with Lyme borreliosis were those with bands with molecular masses of 94, 83, 75, 66, 60, 55, 46, 41, 39, 34, 31, 29, 22, and 17 kDa. The detectable frequencies of most of these proteins appeared to be significantly different between the sera from patients with Lyme borreliosis and those from normal control individuals as well as from the group with syphilis. The 39-kDa protein band recognized by polyvalent antibody was found to be the most significant marker for Lyme borreliosis. Furthermore, an anti-39-kDa immunoglobulin M response was detected in the samples from patients with early-stage Lyme borreliosis. Results from the use of monoclonal antibodies and patient sera revealed that the 39- and 41-kDa proteins may be structurally related but are immunologically distinct antigens. The significance of antibody reactivities to the 41-, 94-, 22-, 31-, and 34-kDa protein bands is also discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537905      PMCID: PMC265062          DOI: 10.1128/jcm.30.2.370-376.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum.

Authors:  R D Fister; L A Weymouth; J C McLaughlin; R W Ryan; R C Tilton
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates.

Authors:  A G Barbour; R A Heiland; T R Howe
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

3.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease.

Authors:  D Nadal; C Taverna; W H Hitzig
Journal:  Pediatr Res       Date:  1989-10       Impact factor: 3.756

6.  Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.

Authors:  W J Simpson; W Burgdorfer; M E Schrumpf; R H Karstens; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.

Authors:  W Jiang; B J Luft; P Munoz; R J Dattwyler; P D Gorevic
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

8.  A Borrelia-specific monoclonal antibody binds to a flagellar epitope.

Authors:  A G Barbour; S F Hayes; R A Heiland; M E Schrumpf; S L Tessier
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.

Authors:  R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

10.  Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid.

Authors:  G T Stiernstedt; M Granström; B Hederstedt; B Sköldenberg
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

View more
  56 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Authors:  Thomas B Ledue; Marilyn F Collins; John Young; Martin E Schriefer
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

3.  Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis.

Authors:  E Hilton; A Tramontano; J DeVoti; S K Sood
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Atypical bilateral symmetric erosive chronic polyarthritis in the course of Lyme disease.

Authors:  J Gutiérrez; M Palermo; M C Maroto; M Abellan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

5.  Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany.

Authors:  P M Rath; B Ibershoff; A Mohnhaupt; J Albig; B Eljaschewitsch; D Jürgens; I Horbach; F J Fehrenbach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

6.  Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph.

Authors:  C M Hu; M Simon; M D Kramer; L Gern
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

7.  Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.

Authors:  S Rauer; N Spohn; C Rasiah; U Neubert; A Vogt
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  Occupational risks of zoonotic infections in Dutch forestry workers and muskrat catchers.

Authors:  A W Moll van Charante; J Groen; P G Mulder; S G Rijpkema; A D Osterhaus
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

9.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.